Continuous Glucose Monitors available for all pregnant women with Type 1 Diabetes

30 March 2021

NHS England have released funding to make Continuous Glucose Monitors (CGM) available for all pregnant women with Type 1 diabetes.

As part of the NHS Long Term Plan, a commitment was made to improve neonatal outcomes by offering Continuous Glucose Monitoring (CGM) to all pregnant women with Type 1 diabetes. As of March 2021, funding has been made available for those eligible to access the technology.

CGM, a sensor which is inserted just under the skin and continuously monitors a user’s glucose levels, can minimise the risks associated with pregnancy and Type 1 diabetes, for both mother and baby.

This life saving equipment is available via our Insulin Pumps Framework and, in support of this initiative, CGM suppliers Medtronic, Medtrum and Dexcom, are offering discounted pricing to enable trusts to purchase the monitors and associated consumables, with the funding provided.

See our Useful Links section to view the Insulin Pumps and Associated Products / Insulin Pumps, Continuous Glucose Monitoring (CGM) and Associated Consumables Framework page.

We are pleased to be supporting NHS England’s initiative as CGM is extremely beneficial to expectant mothers with type 1 diabetes. Not only are they alerted if their blood sugar is too high or too low, the information is instantly available and can be shared with the appropriate care teams. Using CGM helps pregnant women to achieve the best glucose levels possible and reduces the risk of new-born babies needing intensive care treatment post birth, which is something that every parent wishes to avoid.

Leigh Carr, NHS Supply Chain Buyer – Insulin Pumps and CGM

If you are interested in purchasing CGM via the framework and would like to discuss the options available, please contact: